If you are:
Not Recommended: INSUFFICIENT HUMAN DATA; TERATOGENIC IN ANIMALS AT 2 TIMES THE MRHD
Absolute Contraindication: USE NOT RECOMMENDED, CARCINOGENIC IN ANIMAL STUDIES.
An adult over 60:
management or monitoring precaution: Renal-Decrease dosage for CrCL<60 mL/min. Acute renal failure may occur with or without renal failure in the elderly. Insure adequate hydration.
Giving Valcyte to a child under 12:
management or monitoring precaution: Safety and efficacy not established age < 1 month.
management or monitoring precaution: Adhere to dosing guidelines and monitor for neutropenia, infection and signs of overdose; abdominal pain, vomiting, diarrhea, tremor, or seizure.